Option traders moderately bearish in Moderna (MRNA), with shares down $1.72 near $42.35. Options volume roughly in line with average with 82k contracts traded and puts leading calls for a put/call ratio of 1.44, compared to a typical level near 0.67. Implied volatility (IV30) is higher by 0.2 points near 82.36,in the top quartile of the past year, suggesting an expected daily move of $2.20. Put-call skew flattened, suggesting a modestly bullish tone.Looking ahead: Moderna (MRNA) will report earnings before the open on 2026-02-13.Option markets are pricing in a 50% probability of a move greater than 12.56% or $5.32.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Arbutus faces higher bar to argue infringement by Moderna, says Jefferies
- Moderna reverses lower after court issues memo in patent fight with Arbutus
- Moderna rises after Delaware court issues memo in patent fight with Arbutus
- Moderna’s CMV Vaccine Extension Study Reaches Completion, Setting the Stage for Next Growth Catalyst
- SPY ETF Daily Update, 2/2/2026
